CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
1.450
-0.110 (-7.05%)
At close: Nov 5, 2026, 4:00 PM EST
1.450
0.00 (0.00%)
Pre-market: Nov 6, 2026, 8:25 AM EST
CervoMed Market Cap
CervoMed has a market cap or net worth of $21.92 million as of November 5, 2026. It is the 36,032nd most valuable company in the world and the 5,115th biggest in the United States. Its market cap has decreased by 66.25% in one year.
Market Cap
21.92M
Enterprise Value
-3.02M
1-Year Change
-66.25%
Global Rank
Country Rank
#5,115 United States
Category
ChartMarket Cap Chart
Since August 17, 2023, CervoMed's market cap has decreased from $43.26M to $21.92M, a decrease of -49.33%. That is a compound annual growth rate of -19.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 21.92M | -70.01% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
| Aug 17, 2023 | 43.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 24.29M |
| CEL-SCI | 24.10M |
| Celularity | 23.54M |
| NextCure | 23.44M |
| Evaxion | 23.02M |
| Filana Therapeutics | 21.79M |
| Seres Therapeutics | 20.99M |
| Atossa Therapeutics | 20.16M |